Reslizumab Reduces Risk of Severe Asthma Exacerbations – Lung Disease News


Lung Disease News

Reslizumab Reduces Risk of Severe Asthma Exacerbations
Lung Disease News
A total of 953 patients took part in the two double-blind, parallel-group, randomized, placebo-controlled phase 3 trials from 232 health centers around the world. Patients had asthma that has been difficult to control with normal steroid therapy. For

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.